ALLENDALE, N.J., March 4, 2021 /PRNewswire/ -- Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRESPLINE™ and CITRELOCK™ Ligament Reconstruction Devices using their patented CITREGEN™ biomaterial...